nc synthetic nonsteroidal selective estrogen receptor modulator serm development novo nordisk treatment postmenopausal osteoporosis never partial agonist estrogen receptor halfmaximal inhibitory concentration binding inhibition nm halfmaximal effective concentration nm mixed estrogenic antiestrogenic activity shows full estrogenic activity bone uterus emaxtooltip maximal efficacy relative moxestrol ishikawa endometrial cancer cell line compound pyrroloindolizine development discontinued drug article relating genitourinary system stub help wikipedia expanding